Risk of dementia and death in community-dwelling older men with bipolar disorder

British Journal of Psychiatry

Volumn 209, Issue 2, 2016, Pages 121-126

  Almeida, Osvaldo P ^a   McCaul, Kieran ^b   Hankey, Graeme J ^c   Yeap, Bu B ^c   Golledge, Jonathan ^d,e   Flicker, Leon ^b,c,f  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d JAMES COOK UNIVERSITY   (Australia)

^e TOWNSVILLE HOSPITAL   (Australia)

^f ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACCIDENT; AGED; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; COMMUNITY LIVING; DEMENTIA; DIGESTIVE SYSTEM DISEASE; DISEASE ASSOCIATION; ELECTRONIC HEALTH RECORD; GROUPS BY AGE; HAZARD RATIO; HUMAN; INFLUENZA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; RISK FACTOR; SUICIDE; VERY ELDERLY; COMORBIDITY; INDEPENDENT LIVING;

AGED; AGED, 80 AND OVER; BIPOLAR DISORDER; COMORBIDITY; DEMENTIA; HUMANS; INDEPENDENT LIVING; MALE;

EID: 84980349573     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.115.180059     Document Type: Article

References (43)

1. DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelvemonth outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry 2007; 164: 582-90.
2. Mora E, Portella MJ, Forcada I, Vieta E, Mur M. Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: A 6-year follow-up study. Psychol Med 2013; 43: 1187-96.
3. Bourne C, Aydemir O, Balanza-Martinez V, Bora E, Brissos S, Cavanagh JT, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: An individual patient data meta-analysis. Acta Psychiatr Scand 2013; 128: 149-62.
4. Samame C, Martino DJ, Strejilevich SA. A quantitative review of neurocognition in euthymic late-life bipolar disorder. Bipolar Disord 2013; 15: 633-44.
5. Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, et al. Functional outcome in bipolar disorder: The role of clinical and cognitive factors. Bipolar Disord 2007; 9: 103-13.
6. Schouws SN, Comijs HC, Stek ML, Dekker J, Oostervink F, Naarding P, et al. Cognitive impairment in early and late bipolar disorder. Am J Geriatr Psychiatry 2009; 17: 508-15.
7. Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry 2004; 75: 1662-6.
8. Kessing LV, Olsen EW, Mortensen PB, Andersen PK. Dementia in affective disorder: A case-register study. Acta Psychiatr Scand 1999; 100: 176-85.
9. Wu KY, Chang CM, Liang HY, Wu CS, Chia-Hsuan Wu E, Chen CH, et al. Increased risk of developing dementia in patients with bipolar disorder: A nested matched case-control study. Bipolar Disord 2013; 15: 787-94.
10. Kessing LV, Vradi E, Andersen PK. Life expectancy in bipolar disorder. Bipolar Disord 2015; 17: 543-8.
11. Kessing LV, Vradi E, McIntyre RS, Andersen PK. Causes of decreased life expectancy over the life span in bipolar disorder. J Affect Disord 2015; 180: 142-7.
12. Almeida OP, Hankey GJ, Yeap BB, Golledge J, Norman PE, Flicker L. Mortality among people with severe mental disorders who reach old age: A longitudinal study of a community-representative sample of 37, 892 men. PLoS One 2014; 9: E111882.
13. Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: A Swedish national cohort study. JAMA Psychiatry 2013; 70: 931-9.
14. Holman CD, Bass AJ, Rosman DL, Smith MB, Semmens JB, Glasson EJ, et al. A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. Aust Health Rev 2008; 32: 766-77.
15. World Health Organization. International Classification of Diseases, Eighth Revision (ICD-8). WHO, 1965.
16. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). WHO, 1979.
17. World Health Organization. International Classification of Diseases, Tenth Revision (ICD-10). WHO, 1999.
18. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005; 162: 79-91.
19. Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z, Jamrozik K. Cohort Profile: The Health In Men Study (HIMS). Int J Epidemiol 2009; 38: 48-52.
20. McLennan W. Australian Social Trends 1996. Canberra: Australia (Report Catalogue number 4102.0). Australian Bureau of Statistics; 1996.
21. Australian Bureau of Statistics. 3412.0 - Migration, Australia, 2013-14. Australian Bureau of Statistics, 2015 (available at http://www.abs.gov.au/ausstats/abs.nsf/mf/3412.0/(last accessed 4 Feb 2016).
22. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
23. Vardarajan BN, Faber KM, Bird TD, Bennett DA, Rosenberg R, Boeve BF, et al. Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA). JAMA Neurol 2014; 71: 315-23.
24. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord 2003; 73: 261-9.
25. Stone K. Mania in the elderly. Br J Psychiatry 1989; 155: 220-4.
26. Dhingra U, Rabins PV. Mania in the elderly: A 5-7 year follow-up. J Am Geriatr Soc 1991; 39: 581-3.
27. Cerami C, Marcone A, Galimberti D, Villa C, Scarpini E, Cappa SF. From genotype to phenotype: Two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder. J Alzheimers Dis 2011; 27: 791-7.
28. Floris G, Borghero G, Cannas A, Stefano FD, Murru MR, Corongiu D, et al. Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? J Neurol 2013; 260: 1155-7.
29. Moorhead TW, McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC, et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 2007; 62: 894-900.
30. Bauer IE, Pascoe MC, Wollenhaupt-Aguiar B, Kapczinski F, Soares JC. Inflammatory mediators of cognitive impairment in bipolar disorder. J Psychiatr Res 2014; 56: 18-27.
31. Schouws SN, Stek ML, Comijs HC, Beekman AT. Risk factors for cognitive impairment in elderly bipolar patients. J Affect Disord 2010; 125: 330-5.
32. Colpo GD, Leffa DD, Kohler CA, Kapczinski F, Quevedo J, Carvalho AF. Is bipolar disorder associated with accelerating aging? A meta-analysis of telomere length studies. J Affect Disord 2015; 186: 241-8.
33. Kessing LV, Sondergard L, Forman JL, Andersen PK. Lithium treatment and risk of dementia. Arch Gen Psychiatry 2008; 65: 1331-5.
34. Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia? Bipolar Disord 2010; 12: 87-94.
35. Hampel H, Ewers M, Burger K, Annas P, Mortberg A, Bogstedt A, et al. Lithium trial in Alzheimer's disease: A randomized, single-blind, placebocontrolled, multicenter 10-week study. J Clin Psychiatry 2009; 70: 922-31.
36. Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: Randomised controlled trial. Br J Psychiatry 2011; 198: 351-6.
37. Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: A review. Psychiatr Serv 2009; 60: 147-56.
38. Lawrence D, Almeida OP, Hulse GK, Jablensky AV, Holman CD. Suicide and attempted suicide among older adults in Western Australia. Psychol Med 2000; 30: 813-21.
39. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-17.
40. Ritchie SC, Wurtz P, Nath AP, Abraham G, Havulinna AS, Fearnley LG, et al. The biomarker GlycA is associated with chronic inflammation and predicts long-term risk of severe infection. Cell Systems 2015; 1: 293-301.
41. Almeida OP, Alfonso H, Hankey GJ, Flicker L. Depression, antidepressant use and mortality in later life: The Health In Men Study. PLoS One 2010; 5: E11266.
42. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353: 2335-41.
43. Vinkers DJ, Gussekloo J, van der Mast RC, Zitman FG, Westendorp RG. Benzodiazepine use and risk of mortality in individuals aged 85 years or older. JAMA 2003; 290: 2942-3.